Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Bristol’s New Products Meet Early Launch Expectations
Even So, Currency Changes Lead To Lowered Revenue Guidance
Jul 28 2022
•
By
Mandy Jackson
Bristol's Q2 revenue of $11.89bn exceeded analyst consensus • Source: Shutterstock
Keep up with the top pharma business news of the week. On the go.
Scrip brings you a weekly bulletin of top picks.
More from Business
More from Scrip